124 related articles for article (PubMed ID: 2974595)
1. Catabolism of 5-fluoro-2'-deoxyuridine by isolated rat intestinal epithelial cells.
Lin FH; Williams WM
Proc Soc Exp Biol Med; 1988 Dec; 189(3):353-61. PubMed ID: 2974595
[TBL] [Abstract][Full Text] [Related]
2. Effects of pyrimidine nucleoside phosphorylase inhibitors on hepatic fluoropyrimidine elimination in the rat.
LaCreta FP; Warren BS; Williams WM
Cancer Res; 1989 May; 49(10):2567-73. PubMed ID: 2523758
[TBL] [Abstract][Full Text] [Related]
3. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
Woodman PW; Sarrif AM; Heidelberger C
Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286
[TBL] [Abstract][Full Text] [Related]
4. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
[TBL] [Abstract][Full Text] [Related]
5. Ribose-transfer activity from uridine to 5-fluorouracil in Ehrlich ascites tumor cells.
Nabeya Y; Isono K; Moriyama Y; Fujimura S
Jpn J Cancer Res; 1990; 81(6-7):692-700. PubMed ID: 1698195
[TBL] [Abstract][Full Text] [Related]
6. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
el Kouni MH; el Kouni MM; Naguib FN
Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fluoropyrimidine catabolism by benzyloxybenzyluracil. Possible relevance to regional chemotherapy.
Daher GC; Naguib FN; el Kouni MH; Zhang RW; Soong SJ; Diasio RB
Biochem Pharmacol; 1991 Jun; 41(12):1887-93. PubMed ID: 1828154
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine.
Chu MY; Naguib FN; Iltzsch MH; el Kouni MH; Chu SH; Cha S; Calabresi P
Cancer Res; 1984 May; 44(5):1852-6. PubMed ID: 6231986
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent elimination of 5-fluoro-2'-deoxyuridine in the monkey.
Williams WM; Huang KC; Chen TS; Warren BS
Proc Soc Exp Biol Med; 1987 Mar; 184(3):326-36. PubMed ID: 2950526
[TBL] [Abstract][Full Text] [Related]
10. Development of inhibitors of pyrimidine metabolism.
Cha SM
Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111
[TBL] [Abstract][Full Text] [Related]
11. Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
Schwartz PM; Moir RD; Hyde CM; Turek PJ; Handschumacher RE
Biochem Pharmacol; 1985 Oct; 34(19):3585-9. PubMed ID: 2996553
[TBL] [Abstract][Full Text] [Related]
12. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
Roobol C; De Dobbeleer GB; Bernheim JL
Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
Ashour OM; Naguib FN; Khalifa MM; Abdel-Raheem MH; Panzica RP; el Kouni MH
Cancer Res; 1995 Mar; 55(5):1092-8. PubMed ID: 7866994
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
16. Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracil.
Kelley JL; Baker BR
J Med Chem; 1982 May; 25(5):600-3. PubMed ID: 6211547
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells.
Pérignon JL; Bories DM; Houllier AM; Thuillier L; Cartier PH
Biochim Biophys Acta; 1987 Apr; 928(2):130-6. PubMed ID: 3567226
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
19. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
Sweeny DJ; Barnes S; Diasio RB
Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
[TBL] [Abstract][Full Text] [Related]
20. Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.
Sobrero A; Aschele C; Guglielmi A; Nobile MT; Rosso R
J Chemother; 1990 Feb; 2 Suppl 1():12-6. PubMed ID: 2142213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
